 Jeffrey Glasheen
Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitalists | 15 | 2022 | 173 | 3.510 |
Why?
| | Internal Medicine | 10 | 2016 | 215 | 2.090 |
Why?
| | Internship and Residency | 9 | 2022 | 1001 | 1.690 |
Why?
| | Hospital Medicine | 3 | 2022 | 84 | 1.420 |
Why?
| | Leadership | 3 | 2022 | 311 | 1.400 |
Why?
| | Warfarin | 6 | 2011 | 139 | 1.370 |
Why?
| | Academic Medical Centers | 7 | 2017 | 422 | 1.330 |
Why?
| | Quality Improvement | 6 | 2022 | 963 | 1.270 |
Why?
| | Anticoagulants | 5 | 2008 | 559 | 1.000 |
Why?
| | Career Mobility | 2 | 2017 | 66 | 0.960 |
Why?
| | Levofloxacin | 4 | 2008 | 22 | 0.930 |
Why?
| | Ofloxacin | 4 | 2008 | 23 | 0.930 |
Why?
| | Education, Medical, Undergraduate | 2 | 2021 | 199 | 0.910 |
Why?
| | Hospitalization | 5 | 2023 | 1785 | 0.870 |
Why?
| | Models, Educational | 2 | 2015 | 99 | 0.810 |
Why?
| | Hospital Costs | 2 | 2011 | 110 | 0.770 |
Why?
| | Hemorrhage | 3 | 2008 | 623 | 0.650 |
Why?
| | Education, Medical | 3 | 2015 | 239 | 0.580 |
Why?
| | Clinical Competence | 3 | 2015 | 951 | 0.570 |
Why?
| | Mentors | 4 | 2022 | 166 | 0.550 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 102 | 0.540 |
Why?
| | Patient Discharge | 5 | 2016 | 796 | 0.530 |
Why?
| | Stroke | 5 | 2015 | 1047 | 0.530 |
Why?
| | Patient Handoff | 1 | 2015 | 27 | 0.510 |
Why?
| | Medicaid | 2 | 2016 | 411 | 0.510 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2015 | 88 | 0.510 |
Why?
| | Efficiency | 2 | 2011 | 89 | 0.480 |
Why?
| | International Normalized Ratio | 4 | 2008 | 45 | 0.460 |
Why?
| | Faculty, Medical | 3 | 2016 | 252 | 0.460 |
Why?
| | Practice Patterns, Physicians' | 2 | 2011 | 1200 | 0.440 |
Why?
| | Perception | 1 | 2015 | 314 | 0.430 |
Why?
| | Job Satisfaction | 3 | 2022 | 175 | 0.410 |
Why?
| | Medicare | 3 | 2015 | 663 | 0.400 |
Why?
| | Hospitals | 2 | 2023 | 598 | 0.400 |
Why?
| | Hospitals, University | 1 | 2011 | 172 | 0.380 |
Why?
| | Polypharmacy | 1 | 2011 | 75 | 0.380 |
Why?
| | Cooperative Behavior | 2 | 2011 | 408 | 0.370 |
Why?
| | Humans | 42 | 2023 | 118974 | 0.360 |
Why?
| | Patient Readmission | 2 | 2013 | 634 | 0.360 |
Why?
| | Burnout, Professional | 3 | 2011 | 330 | 0.330 |
Why?
| | Ischemic Attack, Transient | 1 | 2009 | 62 | 0.320 |
Why?
| | Inservice Training | 1 | 2009 | 106 | 0.320 |
Why?
| | Anti-Bacterial Agents | 2 | 2008 | 1510 | 0.320 |
Why?
| | Delivery of Health Care | 2 | 2021 | 867 | 0.320 |
Why?
| | Dysentery | 1 | 2007 | 1 | 0.310 |
Why?
| | Curriculum | 5 | 2022 | 910 | 0.310 |
Why?
| | Physicians | 2 | 2015 | 794 | 0.300 |
Why?
| | Patient Care Team | 1 | 2011 | 521 | 0.290 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2008 | 117 | 0.280 |
Why?
| | Career Choice | 2 | 2022 | 192 | 0.270 |
Why?
| | Communication | 1 | 2011 | 761 | 0.260 |
Why?
| | Acidosis, Lactic | 1 | 2005 | 29 | 0.260 |
Why?
| | Length of Stay | 3 | 2016 | 1032 | 0.260 |
Why?
| | Feces | 1 | 2007 | 396 | 0.250 |
Why?
| | Drug Interactions | 4 | 2008 | 352 | 0.250 |
Why?
| | Burkitt Lymphoma | 1 | 2005 | 53 | 0.250 |
Why?
| | Blood Pressure | 2 | 2009 | 1664 | 0.240 |
Why?
| | Stress, Psychological | 1 | 2011 | 972 | 0.220 |
Why?
| | Hypercapnia | 1 | 2002 | 50 | 0.220 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 227 | 0.220 |
Why?
| | Hypothyroidism | 1 | 2002 | 68 | 0.220 |
Why?
| | Academies and Institutes | 1 | 2022 | 44 | 0.210 |
Why?
| | Primary Health Care | 1 | 2011 | 1560 | 0.200 |
Why?
| | Organizational Innovation | 2 | 2015 | 138 | 0.200 |
Why?
| | Emergency Service, Hospital | 1 | 2011 | 1865 | 0.190 |
Why?
| | Hypoglycemia | 1 | 2005 | 400 | 0.180 |
Why?
| | Inpatients | 1 | 2023 | 388 | 0.180 |
Why?
| | Risk Assessment | 1 | 2009 | 3057 | 0.180 |
Why?
| | United States | 7 | 2016 | 12555 | 0.180 |
Why?
| | Fellowships and Scholarships | 1 | 2022 | 250 | 0.170 |
Why?
| | Program Evaluation | 1 | 2022 | 845 | 0.160 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 4552 | 0.150 |
Why?
| | Insurance, Health | 2 | 2015 | 244 | 0.140 |
Why?
| | Hospital Mortality | 2 | 2021 | 814 | 0.140 |
Why?
| | Students | 1 | 2021 | 509 | 0.140 |
Why?
| | Uncompensated Care | 1 | 2015 | 17 | 0.140 |
Why?
| | Retrospective Studies | 7 | 2021 | 12978 | 0.130 |
Why?
| | Medically Uninsured | 1 | 2015 | 125 | 0.130 |
Why?
| | Mentoring | 1 | 2016 | 101 | 0.120 |
Why?
| | Aged | 8 | 2015 | 19657 | 0.120 |
Why?
| | Hospitals, Special | 1 | 2013 | 11 | 0.120 |
Why?
| | Pandemics | 1 | 2021 | 1355 | 0.110 |
Why?
| | Female | 13 | 2022 | 61565 | 0.110 |
Why?
| | Workload | 2 | 2011 | 128 | 0.110 |
Why?
| | Male | 12 | 2016 | 57801 | 0.110 |
Why?
| | Evidence-Based Practice | 1 | 2013 | 193 | 0.100 |
Why?
| | Risk Factors | 5 | 2015 | 9000 | 0.100 |
Why?
| | Continuity of Patient Care | 1 | 2013 | 265 | 0.100 |
Why?
| | Health Services for the Aged | 1 | 2011 | 71 | 0.100 |
Why?
| | Specialties, Surgical | 1 | 2011 | 76 | 0.090 |
Why?
| | Time Factors | 2 | 2011 | 6412 | 0.090 |
Why?
| | Cerebral Hemorrhage | 1 | 2011 | 100 | 0.090 |
Why?
| | Patient Safety | 1 | 2013 | 281 | 0.090 |
Why?
| | Adult | 7 | 2022 | 31512 | 0.090 |
Why?
| | Blood Cell Count | 1 | 2009 | 53 | 0.090 |
Why?
| | Speech Disorders | 1 | 2009 | 35 | 0.090 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2007 | 81 | 0.080 |
Why?
| | Tissue Plasminogen Activator | 1 | 2011 | 231 | 0.080 |
Why?
| | Data Collection | 1 | 2011 | 658 | 0.080 |
Why?
| | Histamine H1 Antagonists | 1 | 2008 | 33 | 0.080 |
Why?
| | Diagnostic Tests, Routine | 1 | 2009 | 88 | 0.080 |
Why?
| | Geriatrics | 1 | 2008 | 68 | 0.080 |
Why?
| | Neurology | 1 | 2009 | 94 | 0.080 |
Why?
| | Carotid Arteries | 1 | 2009 | 184 | 0.080 |
Why?
| | Models, Organizational | 1 | 2008 | 146 | 0.080 |
Why?
| | Benzodiazepines | 1 | 2008 | 122 | 0.070 |
Why?
| | Critical Care | 1 | 2011 | 492 | 0.070 |
Why?
| | Hypnotics and Sedatives | 1 | 2008 | 136 | 0.070 |
Why?
| | Disabled Persons | 1 | 2009 | 147 | 0.070 |
Why?
| | Internet | 1 | 2011 | 633 | 0.070 |
Why?
| | Antidepressive Agents | 1 | 2008 | 189 | 0.070 |
Why?
| | Cost-Benefit Analysis | 1 | 2009 | 554 | 0.070 |
Why?
| | Secondary Prevention | 1 | 2007 | 227 | 0.070 |
Why?
| | Electrocardiography | 1 | 2009 | 556 | 0.070 |
Why?
| | Prazosin | 1 | 2005 | 22 | 0.070 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2005 | 37 | 0.070 |
Why?
| | Lipids | 1 | 2009 | 607 | 0.070 |
Why?
| | Patient Selection | 1 | 2009 | 676 | 0.060 |
Why?
| | Atrial Fibrillation | 1 | 2009 | 338 | 0.060 |
Why?
| | Ultrasonography | 1 | 2009 | 716 | 0.060 |
Why?
| | Azithromycin | 1 | 2005 | 81 | 0.060 |
Why?
| | Fatal Outcome | 1 | 2005 | 287 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 1868 | 0.060 |
Why?
| | Tumor Burden | 1 | 2005 | 274 | 0.060 |
Why?
| | Middle Aged | 4 | 2015 | 27617 | 0.060 |
Why?
| | Referral and Consultation | 1 | 2008 | 648 | 0.060 |
Why?
| | Thrombosis | 1 | 2007 | 309 | 0.060 |
Why?
| | Antihypertensive Agents | 1 | 2007 | 437 | 0.060 |
Why?
| | Surveys and Questionnaires | 3 | 2011 | 4708 | 0.060 |
Why?
| | Neoplasm Invasiveness | 1 | 2005 | 462 | 0.060 |
Why?
| | Cohort Studies | 2 | 2021 | 5116 | 0.060 |
Why?
| | Prospective Studies | 3 | 2023 | 6471 | 0.060 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 693 | 0.060 |
Why?
| | Administration, Oral | 1 | 2005 | 756 | 0.060 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 253 | 0.050 |
Why?
| | Monitoring, Physiologic | 1 | 2005 | 272 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2023 | 162 | 0.050 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2007 | 1244 | 0.050 |
Why?
| | Age Factors | 1 | 2009 | 2995 | 0.050 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2005 | 402 | 0.050 |
Why?
| | Feedback | 1 | 2022 | 153 | 0.050 |
Why?
| | Reference Values | 1 | 2002 | 774 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2003 | 965 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2007 | 992 | 0.040 |
Why?
| | Hypertension | 1 | 2007 | 1203 | 0.040 |
Why?
| | Colorado | 3 | 2013 | 4196 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2009 | 9342 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2021 | 829 | 0.030 |
Why?
| | Medicine | 1 | 2016 | 106 | 0.030 |
Why?
| | Young Adult | 1 | 2008 | 10793 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 190 | 0.030 |
Why?
| | Education | 1 | 2013 | 105 | 0.030 |
Why?
| | Congresses as Topic | 1 | 2013 | 204 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2013 | 599 | 0.020 |
Why?
| | Comprehension | 1 | 2013 | 163 | 0.020 |
Why?
| | Medical Audit | 1 | 2011 | 75 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2015 | 635 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2013 | 6561 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 210 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 169 | 0.020 |
Why?
| | Self Care | 1 | 2013 | 357 | 0.020 |
Why?
| | Thrombolytic Therapy | 1 | 2011 | 118 | 0.020 |
Why?
| | Self Efficacy | 1 | 2013 | 366 | 0.020 |
Why?
| | Palliative Care | 1 | 2015 | 629 | 0.020 |
Why?
| | Sepsis | 1 | 2015 | 531 | 0.020 |
Why?
| | Training Support | 1 | 2008 | 24 | 0.020 |
Why?
| | Work Schedule Tolerance | 1 | 2005 | 36 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2005 | 586 | 0.010 |
Why?
| | Longitudinal Studies | 1 | 2005 | 2513 | 0.010 |
Why?
|
|
Glasheen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|